Absorbed dose microdistribution of 177Lu and 225Ac in a model of cancer associated fibroblasts

被引:0
|
作者
Tranel, J. [1 ]
Palm, S. [2 ]
Graves, S. A. [3 ]
Feng, F. Y. [1 ]
Hope, T. A. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Gothenburg, Gothenburg, Sweden
[3] Univ Iowa, Iowa City, IA USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-625
引用
收藏
页码:S209 / S209
页数:1
相关论文
共 50 条
  • [21] Molecular imaging and biochemical response assessment after a single cycle of [225Ac]Ac-PSMA-617/[177Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [177Lu]Lu-PSMA-617 monotherapy
    Rosar, Florian
    Hau, Fabian
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    THERANOSTICS, 2021, 11 (09): : 4050 - 4060
  • [22] Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
    Rosar, Florian
    Krause, Jonas
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Hierlmeier, Ina
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    PHARMACEUTICS, 2021, 13 (05)
  • [23] Is 212Pb Really Happening? The Post-177Lu/225Ac Blockbuster?
    Zimmermann, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (02) : 176 - 177
  • [24] AcTION: A phase 1 study of [225Ac]Ac-PSMA-617 in men with PSMA-positive prostate cancer with or without prior [177Lu]Lu-PSMA-617 radioligand therapy
    Sathekge, M.
    Crumbaker, M.
    Joshua, A. M.
    Bruchertseifer, F.
    Kreisl, T.
    Emineni, S.
    Wehbe, J.
    Korn, M.
    Morgenstern, A.
    Emmett, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S152 - S153
  • [25] First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
    Maryana Handula
    Savanne Beekman
    Mark Konijnenberg
    Debra Stuurman
    Corrina de Ridder
    Frank Bruchertseifer
    Alfred Morgenstern
    Antonia Denkova
    Erik de Blois
    Yann Seimbille
    EJNMMI Radiopharmacy and Chemistry, 8
  • [26] First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
    Handula, Maryana
    Beekman, Savanne
    Konijnenberg, Mark
    Stuurman, Debra
    de Ridder, Corrina
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Denkova, Antonia
    de Blois, Erik
    Seimbille, Yann
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [27] Novel FAPi Dimers for Broad Theranostic Applications: 225Ac/177Lu/90Y/68Ga-Radiolabeling and in vitro Evaluation
    Martin, M.
    Van Rymenant, Y.
    De Loose, J.
    Verhulst, E.
    Van der Veken, P.
    De Meester, I.
    Roesch, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S326 - S327
  • [28] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Astrid Delker
    Mirjam Schleske
    Grigory Liubchenko
    Isabella Berg
    Mathias Johannes Zacherl
    Matthias Brendel
    Franz Josef Gildehaus
    Mikhail Rumiantcev
    Sandra Resch
    Kerstin Hürkamp
    Vera Wenter
    Lena M. Unterrainer
    Peter Bartenstein
    Sibylle I. Ziegler
    Leonie Beyer
    Guido Böning
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1280 - 1290
  • [29] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Delker, Astrid
    Schleske, Mirjam
    Liubchenko, Grigory
    Berg, Isabella
    Zacherl, Mathias Johannes
    Brendel, Matthias
    Gildehaus, Franz Josef
    Rumiantcev, Mikhail
    Resch, Sandra
    Huerkamp, Kerstin
    Wenter, Vera
    Unterrainer, Lena M.
    Bartenstein, Peter
    Ziegler, Sibylle, I
    Beyer, Leonie
    Boening, Guido
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1280 - 1290
  • [30] Relationship between absorbed dose and response in neuroendocrine tumors treated with [177Lu]Lu-DOTA-TATE
    Warfvinge, C. F.
    Gustafsson, J.
    Roth, D.
    Tennvall, J.
    Svensson, J.
    Bernhardt, P.
    Akesson, A.
    Wieslander, E.
    Sundlov, A.
    Gleisner, Sjogreen K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 221 - 221